Mohamed Nagy (Mohamad Nagy)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Venues

Personalized medicine

Clinical pharmacology and therapeutics

Pharmacogenomics

Immunotherapy

Children's Cancer Hospital Egypt 57357

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Children's Cancer Hospital Egypt 57357

Egypt

Head of Personalized Medication Management Unit :: Pharmaceutical Services

Publications

Julio D Duarte, Cameron D Thomas, And Craig R Lee, Rachel Huddart, José A G Agúndez, Jordan F Baye, Andrea Gaedigk, Teri E Klein, David E Lanfear, Andrew A Monte, Mohamed Nagy, Matthias Schwab, C Michael Stein, Chakradhara Rao Satyanarayana Uppugunduri, Ron H N van Schaik, Roseann S Donnelly, Kelly E Caudle, Jasmine A Luzum
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy. Clinical pharmacology and therapeutics (2024)
Rewan Gamal Mohamed, Rania Saber, Mohamed Ali Hussein, Amira Shalaby, Nouran Yasser, Sherif Kamal, Lobna Shalaby, Mohamed Nagy
Optimizing vancomycin therapeutic drug monitoring compliance in pediatric oncology: towards personalized medication management. Personalized medicine (2024)
Julio D Duarte, Cameron D Thomas, And Craig R Lee, Rachel Huddart, José A G Agúndez, Jordan F Baye, Andrea Gaedigk, Teri E Klein, David E Lanfear, Andrew A Monte, Mohamed Nagy, Matthias Schwab, C Michael Stein, Chakradhara Rao Satyanarayana Uppugunduri, Ron H N van Schaik, Roseann S Donnelly, Kelly E Caudle, Jasmine A Luzum
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy. Clinical pharmacology and therapeutics (2024)
Mohamed Kamal, Mohamed Nagy, Omneya Hassanain
Improving resource allocation in the precision medicine Era: a simulation-based approach using R. Personalized medicine 21 (3) (2024)
Rewan Gamal Mohamed, Rania Saber, Mohamed Ali Hussein, Amira Shalaby, Nouran Yasser, Sherif Kamal, Lobna Shalaby, Mohamed Nagy
Optimizing vancomycin therapeutic drug monitoring compliance in pediatric oncology: towards personalized medication management. Personalized medicine 21 (4) (2024)
Sahar Hassan, Omneya Hassanain, Sherif Kamal, Lobna Shalaby, Mohamed Nagy
Knowledge, attitudes and practices of Egyptian healthcare professionals toward therapeutic drug monitoring service as a principal component of personalized medicine. Personalized medicine 19 (6) (2022)
Mai Alalawi, Abrar Saeed Bakr, Rowaida Reda, Karim Thomas Sadak, Mohamed Nagy
Late-onset toxicities of monoclonal antibodies in cancer patients. Immunotherapy 14 (13) (2022)
Alaa Abdel Aziz, Sara L Rogers, Omneya Hassanien, Lobna Shalaby, Mohamed Nagy
Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation. Personalized medicine 19 (6) (2022)
Mohamed Nagy, Evangelia Eirini Tsermpini, Stavroula Siamoglou, George P Patrinos
Evaluating the current level of pharmacists' pharmacogenomics knowledge and its impact on pharmacogenomics implementation. Pharmacogenomics 21 (16) (2020)
Mohamed Nagy, Mohamed Attya, George P Patrinos
Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies. Pharmacogenomics 21 (17) (2020)
Mohamed Nagy, Meghan Lynch, Sherif Kamal, Sarah Mohamed, Alaa Hadad, Sherif Abouelnaga, Christina L Aquilante
Assessment of healthcare professionals' knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt. Personalized medicine 17 (4) (2020)

Mohamed Nagy.css-eqlu8i{font-size:small;padding-left:4px;} (Mohamad Nagy)

Publication Activity (10 Years)

Top Topics

Top Venues

Mohamed Nagy (Mohamad Nagy)